BioCentury
ARTICLE | Clinical News

ACT 1: Phase II data

October 20, 2014 7:00 AM UTC

An Indian Phase II trial in patients with chronic venous leg ulcers showed that topical Granexin gel plus standard of care (SOC) significantly reduced mean percent ulcer area from baseline to week 12 ...